Home
Jennifer L. Good, President & CEO: Trevi Therapeutics TRVI Sell · Filed 25/03/25
Trade details
- Type
- Insider sale
- Amount
- $34,630.54
- Shares · price
- 5,263 sh · $6.58 a share
- Held after
- 213,313 sh
- Trade date
- 25/03/21
- Filed
- 25/03/25
- Days to filing
- 4 days
Sold 2.4% of holdings
- Share of holding sold
- 2.4%
Trevi Therapeutics trades, last 26 weeks
What else happened in Trevi Therapeutics around then
Filed or reported within 30 days of the trade day · 25/02/19~25/04/20Jennifer L. Good's recent trades
- Jennifer L. Good
Planned saleTrevi Therapeutics
Planned saleTrevi Therapeutics
TRVI
$34.6K
5,263 sh
$34.6K
Filed 25/03/21
Traded 25/03/21
- Jennifer L. Good
Sell10b5-1 planRhythm Pharmaceuticals
Sell10b5-1 planRhythm Pharmaceuticals
RYTM
$1.7M
31,751 sh
$1.7M
Filed 24/09/19
Traded 24/09/17
- Jennifer L. Good
Sell10b5-1 planRhythm Pharmaceuticals
Sell10b5-1 planRhythm Pharmaceuticals
RYTM
$1.9M
37,241 sh
$1.9M
Filed 24/09/11
Traded 24/09/09
- Jennifer L. Good
SellTrevi Therapeutics
SellTrevi Therapeutics
TRVI
$12.8K
4,219 sh
$12.8K
Filed 24/09/09
Traded 24/09/06
- Jennifer L. Good
SellTrevi Therapeutics
SellTrevi Therapeutics
TRVI
$5,594
1,840 sh
$5,594
Filed 24/09/09
Traded 24/09/09
